Document Detail

Platinum chemotherapy for BRCA1-related breast cancer: do we need more evidence?
MedLine Citation:
PMID:  23146216     Owner:  NLM     Status:  Publisher    
ABSTRACT: A recent prospective clinical trial provides further evidence that breast cancers arising in germline BRCA1 mutation carriers are highly sensitive to cisplatin chemotherapy. The potential significance of these data for the management of patients with BRCA1-related and BRCA2-related breast cancer is discussed.
Nicholas C Turner; Andrew Nj Tutt
Related Documents :
1693796 - Quantification of prostatic cancer metastatic disease using prostate-specific antigen.
20354276 - Expression of matrix metalloproteinase-9 in prostate cancer. preliminary experience.
23642526 - Phase ii open-label study of bevacizumab combined with neoadjuvant anthracycline and ta...
2468276 - Is prostate-specific antigen the most useful marker for screening in prostate cancer?
18841336 - Japanese late-onset breast cancer families: their clinicopathological characteristics a...
21744256 - Multifocal, multicentric and contralateral breast cancers: breast mr imaging in the pre...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-13
Journal Detail:
Title:  Breast cancer research : BCR     Volume:  14     ISSN:  1465-542X     ISO Abbreviation:  Breast Cancer Res.     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100927353     Medline TA:  Breast Cancer Res     Country:  -    
Other Details:
Languages:  ENG     Pagination:  115     Citation Subset:  -    
The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Use of miglustat in a child with late-infantile-onset Niemann-Pick disease type C and frequent seizu...
Next Document:  Foodborne cryptosporidiosis: is there really more in Nordic countries?